The Latest Cancer Drugs News
Browsing: Cancer Drug News
ICR welcomes NICE’s decision to reassess abiraterone as first-line treatment for advanced prostate cancer
The Institute of Cancer Research, London, UK, has welcomed the announcement by NICE that it…
BMS Announces EU approval of first-line treatment option for advanced non-small cell lung cancer
Bristol Myers Squibb (NYSE: BMY) announced that the European Commission (EC) has approved Opdivo (nivolumab)…
New analysis method can lead to better cancer drugs
While proteins on the surface of cells are the targets for most drugs, refined methods…
Large-scale cancer proteomics study profiles protein changes in response to drug treatments
Through large-scale profiling of protein changes in response to drug treatments in cancer cell lines,…
Machine learning predicts anti-cancer drug efficacy
With the advent of pharmacogenomics, machine learning research is well underway to predict the patients’…
‘Time machine’ offers new pancreatic cancer drug testing approach
Many patients with pancreatic cancer have only about a 10% chance of survival within five…
Scientists discover new anti-cancer molecule
A group of Moscow scientists has discovered and explained the activity mechanism of a new…
New drug for difficult-to-drug cancer mutation could be key treatment for a range of cancers
A new drug designed to counter the effects of an important, but very hard to…
ICR calls for change to bring immunotherapies to more cancer patients
Major changes to the way immunotherapy drugs are researched and evaluated are essential if they…
Response to adjuvant bevacizumab among patients with resected melanoma may vary by age
Younger patients with resected melanoma had some benefit from adjuvant treatment with the anti-VEGF therapeutic…